Science Advisory Board
Dr. Paul C. Wey - Certified Pharmaceutical Scientist | Member, ICNPR
Dr. Paul C.Wey holds a Ph.D. in Drug Discovery and Development Industry from the College of Pharmacy, Taipei Medical University. As a member of the International Conference on Natural Products Research (ICNPR), Paul specializes in natural product pharmacology, nanotechnology-based drug delivery, and pharmaceutical innovation.
Currently leading research at a private independent R&D institution, Paul focuses on translating cutting-edge scientific advancements into applied therapeutics and functional skincare formulations. His work bridges academic research and industrial applications, optimizing bioavailability and stability of active compounds through advanced formulation strategies.
Dr. Ignacio Urbina - Chemist | Specialist in Bioactive Compounds | Adolfo Ibáñez University, Chile
Ignacio Urbina is a trained chemist with a strong academic foundation in organic and analytical chemistry, earned from Adolfo Ibáñez University in Chile. His work focuses on the identification, extraction, and stabilization of bioactive compounds from natural sources, particularly within the context of functional ingredients for health and skincare applications.
Mr. Urbina has collaborated with multidisciplinary research teams across Latin America in the development of sustainable extraction processes and innovative formulations that preserve the biological activity of plant-derived compounds. His areas of expertise include natural antioxidants, essential oils, and botanical emulsions, with emphasis on efficacy, safety, and environmental impact.
Currently engaged in independent formulation research, he works closely with both academic institutions and private-sector partners to bridge lab-scale innovation with real-world product development, applying advanced chemical methodologies to ensure quality and consistency in active ingredient delivery.
Dr. Benni Iskandar - General Practicioner in Syafira Hospital, Pekanbaru, Indonesia
Dr. Benni Iskandar obtained his doctoral degree from the School of Pharmacy, College of Pharmacy, Taipei Medical University, Taiwan. His expertise lies in pharmaceutical technology, nanoparticle-based drug delivery systems, and cosmetic formulations. Recognized as a distinguished figure in the field, he has made substantial contributions through numerous high-impact publications. His research portfolio includes over 19 articles in internationally accredited journals (Scopus and WOS), more than 40 publications in nationally indexed SINTA journals, and notable citation metrics, with an H-Index of 8 on Google Scholar (as of March 2025) and an H-Index of 5 on Scopus.
Dr. Benni's research is centered on the advancement of innovative drug delivery systems, particularly utilizing nanotechnology to improve the effectiveness, bioavailability, and stability of active pharmaceutical ingredients (APIs) in formulation and cosmetic preparation.
Dr. Fitri Renovita - General Practicioner in Syafira Hospital, Pekanbaru, Indonesia
Dr. Fitri Renovita is a medical doctor who graduated from the College of Medicine at Muhammadiyah University, Indonesia. She is recognized as a distinguished figure in the field, with a strong focus on cosmetic science and general practice. Her expertise lies in developing innovative drug delivery systems, particularly in dermatological and skincare applications. Through her research, she aims to optimize formulations that enhance both efficacy and safety, contributing to advancements in pharmaceutical and cosmetic sciences.
Mark Huang - Chemical Engineering Specialist | Expert in Dermatological Formulations
Mark Huang holds a Bachelor’s degree in Chemical Engineering from National Taiwan University and a Master’s degree in Chemical Engineering from the University of Southern California. With a strong foundation in chemical sciences and biomedical applications, his work focuses on advancing dermatological formulations through a scientific and evidence-based approach.
His expertise lies in the development of bioactive compounds with clinically proven efficacy, emphasizing skin barrier repair, anti-inflammatory mechanisms, and transdermal drug delivery. Mark has spearheaded research initiatives leading to innovative therapeutic formulations, optimizing biocompatibility and enhancing treatment outcomes. His contributions have been recognized through multiple international patents, reinforcing his role in bridging chemical research and medical skincare innovation.